USA: A novel RNA interference (RNAi) therapy targeting angiopoietin-like protein 3 (ANGPTL3) has shown promising lipid-lowering effects in patients with homozygous familial hypercholesterolaemia (HoFH), a rare genetic disorder associated with…
Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health markers such as high cholesterol and high blood pressure, finds a…
Higher intake of food preservatives, widely used in industrially processed foods and beverages to extend shelf-life, is associated with a modestly increased risk of cancer, finds a study from France…
New Delhi: Hyderabad-based Natco Pharma has approached the Delhi High Court with a petition seeking revocation of a patent held by Novo Nordisk, the Danish drugmaker behind the weight-loss medication…
For millions suffering from chronic inflammatory diseases like inflammatory bowel disease (IBD), managing flare-ups often involves powerful drugs with significant side effects. A new study published in National Science Review…
Researchers have found in a new study that flowable short fiber–reinforced resin composite demonstrated significantly higher fracture resistance under both monotonic static loading and repeated subcritical stress. Its consistently superior…
USA: A randomized clinical trial published in JAMA Internal Medicine suggests that a collaborative care model adapted for low-resource primary care settings does not provide additional benefit over enhanced usual…
Vinoth Thangamani et al conducted a study to assess the radiological, clinical, and neurological outcome of patients who had thoracolumbar burst fractures and had undergone short-segment posterior stabilization with single-index…
Cipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
A new study published in the journal of BMC Women’s Health showed that uterine fibroids (UF) may shrink if vitamin D supplements and animal-based forms of vitamin A are consumed.…